These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 9679456
21. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma. Nakagawa H, Matsumiya T, Sakaki H, Imaizumi T, Kubota K, Kusumi A, Kobayashi W, Kimura H. Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889 [Abstract] [Full Text] [Related]
22. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor. Webber J, Leeson B, Fromm D, Kessel D. J Photochem Photobiol B; 2005 Feb 01; 78(2):135-40. PubMed ID: 15664500 [Abstract] [Full Text] [Related]
23. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis. Usuda J, Okunaka T, Furukawa K, Tsuchida T, Kuroiwa Y, Ohe Y, Saijo N, Nishio K, Konaka C, Kato H. Int J Cancer; 2001 Aug 15; 93(4):475-80. PubMed ID: 11477550 [Abstract] [Full Text] [Related]
24. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398. Harvey EH, Webber J, Kessel D, Fromm D. Am J Surg; 2005 Mar 15; 189(3):302-5. PubMed ID: 15792755 [Abstract] [Full Text] [Related]
25. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6). Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM. Ophthalmology; 1999 Jul 15; 106(7):1384-91. PubMed ID: 10406627 [Abstract] [Full Text] [Related]
26. Conjugation of chlorin p(6) to histamine enhances its cellular uptake and phototoxicity in oral cancer cells. Parihar A, Dube A, Gupta PK. Cancer Chemother Pharmacol; 2011 Aug 15; 68(2):359-69. PubMed ID: 20978762 [Abstract] [Full Text] [Related]
27. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6]. Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y. Nippon Ganka Gakkai Zasshi; 1997 Feb 15; 101(2):134-40. PubMed ID: 9124093 [Abstract] [Full Text] [Related]
28. Bid is required in NPe6-PDT-induced apoptosis. Wan Q, Liu L, Xing D, Chen Q. Photochem Photobiol; 2008 Feb 15; 84(1):250-7. PubMed ID: 18173728 [Abstract] [Full Text] [Related]
29. Effect of pH on uptake and photodynamic action of chlorin p6 on human colon and breast adenocarcinoma cell lines. Sharma M, Dube A, Bansal H, Kumar Gupta P. Photochem Photobiol Sci; 2004 Feb 15; 3(2):231-5. PubMed ID: 14872242 [Abstract] [Full Text] [Related]
30. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessels and its contribution to the antitumor effect. Saito K, Mikuniya N, Aizawa K. Jpn J Cancer Res; 2000 May 15; 91(5):560-5. PubMed ID: 10835502 [Abstract] [Full Text] [Related]
31. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy. Nelson JS, Roberts WG, Berns MW. Cancer Res; 1987 Sep 01; 47(17):4681-5. PubMed ID: 2957047 [Abstract] [Full Text] [Related]
32. Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells. Miki Y, Akimoto J, Moritake K, Hironaka C, Fujiwara Y. Lasers Med Sci; 2015 Aug 01; 30(6):1739-45. PubMed ID: 26109138 [Abstract] [Full Text] [Related]
34. Pharmacokinetics and phototoxicity of purpurin-18 in human colon carcinoma cells using liposomes as delivery vehicles. Sharma S, Dube A, Bose B, Gupta PK. Cancer Chemother Pharmacol; 2006 Apr 01; 57(4):500-6. PubMed ID: 16075277 [Abstract] [Full Text] [Related]
35. Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter. Usuda J, Ichinose S, Ishizumi T, Hayashi H, Ohtani K, Maehara S, Ono S, Honda H, Kajiwara N, Uchida O, Tsutsui H, Ohira T, Kato H, Ikeda N. Clin Cancer Res; 2010 Apr 01; 16(7):2198-204. PubMed ID: 20332318 [Abstract] [Full Text] [Related]
36. Design, synthesis and biological evaluation of novel 31-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy. Zhang XJ, Han GY, Guo CY, Ma ZQ, Lin MY, Wang Y, Miao ZY, Zhang WN, Sheng CQ, Yao JZ. Eur J Med Chem; 2020 Dec 01; 207():112715. PubMed ID: 32846322 [Abstract] [Full Text] [Related]
37. Sonodynamically-induced antitumor effect of mono-l-aspartyl chlorin e6 (NPe6). Yumita N, Iwase Y, Nishi K, Ikeda T, Komatsu H, Fukai T, Onodera K, Nishi H, Takeda K, Umemura S, Okudaira K, Momose Y. Anticancer Res; 2011 Feb 01; 31(2):501-6. PubMed ID: 21378330 [Abstract] [Full Text] [Related]
38. Effect of increased hydrophobicity on the binding of two model amphiphilic chlorin drugs for photodynamic therapy with blood plasma and its components. Mishra PP, Patel S, Datta A. J Phys Chem B; 2006 Oct 26; 110(42):21238-44. PubMed ID: 17048951 [Abstract] [Full Text] [Related]
39. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels. Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I. Ophthalmic Surg Lasers; 2000 Oct 26; 31(4):323-7. PubMed ID: 10928670 [Abstract] [Full Text] [Related]
40. Skin fluorescence following photodynamic therapy with NPe6 photosensitizer. Ohtani K, Usuda J, Ogawa E, Maehara S, Imai K, Kudo Y, Ono S, Shigefuku S, Eriguchi D, Inoue T, Maeda J, Yoshida K, Hagiwara M, Kakihana M, Kajiwara N, Ohira T, Arai T, Ikeda N. Photodiagnosis Photodyn Ther; 2017 Dec 26; 20():210-214. PubMed ID: 28988135 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]